Search for: "Pfizer Inc." Results 721 - 740 of 1,379
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2012, 10:02 pm by Linda Moss
The three drugs in final tests, according to AP, are: Bapineuzumab, from Pfizer Inc. and Johnson & Johnson; Solanezumab, from Eli Lilly & Co.; and Gammagard, from Baxter International Inc. [read post]
4 Apr 2007, 6:00 am
Reply Brief on the Merits (filed 02/22/07) Amicus Curiae Brief of Pacific Legal Foundation (submitted 03/23/07; filed 04/04/07) Amicus Curiae Brief of Consumer Attorneys of California (submitted 03/26/07) Amicus Curiae Brief of Pfizer, Inc. [read post]
12 May 2009, 7:50 am
" Baxter is quoted in the article as stating that "the heparin involved in the cases of the two patients who died is from North American-derived bulk material supplied by Pfizer Inc. [read post]
26 May 2010, 4:09 am by Anthony Lake
Notable settlements in this area include Pfizer, Inc., which, at $2.3 billion, constitutes the largest healthcare fraud settlement in U.S. history, Eli Lilly Company; Abbott Laboratories, Inc.; and Bayer Healthcare, LLC. [read post]
16 Feb 2010, 3:45 am by Sean Wajert
Pfizer, Inc., 356 F.3d 1326, 1334 (10th Cir.), cert. denied, 543 U.S. 917 (2004). [read post]
31 Jul 2013, 8:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
13 Mar 2013, 8:35 am
Z-Paks, which are marketed by Pfizer Inc., have only been around for about 20 years, which means we may yet have a lot to learn. [read post]
19 Aug 2011, 9:23 am by Stephen Jenei
Teva’s Lawsuit Against Viagra Patent Wilts Pfizer Inc. [read post]
22 Apr 2013, 2:43 pm by Fraud Fighters
  Pfizer – $491 million Pfizer announced a $491 million charge to settle a case initially filed against Wyeth (a drug company acquired by Pfizer in 2009). [read post]
10 Feb 2010, 4:47 pm
Sepracor Inc (EPLAW) Zyvox (Linezolid) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]